Appetite for destruction: E3 ubiquitin-ligase protection in cardiac disease

Monte Willis, Jonathan C. Schisler, Cam Patterson

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

Over the course of 3 billion heartbeats in an average human lifetime, the heart must maintain constant protein quality control, including the coordinated and regulated degradation of proteins via the ubiquitin-proteasome system (UPS). Recent data highlight the specificity by which the UPS functions in the context of cardiac hypertrophy, ischemic heart disease and cardiomyopathies. Although curbing the appetite of the proteasome through the use of inhibitors in animal models of cardiac disease has proven effective experimentally recent studies report proteasome inhibition as being cardiotoxic in some patients. Therefore, focusing on specific regulatory components of the proteasome, such as members of the E3 ubiquitin-ligase family of proteins, may hold promise for targeted therapeutics of cardiac disease. This review focuses on the UPS, its specific role in cardiac disease and opportunities for novel therapies.

Original languageEnglish (US)
Pages (from-to)65-75
Number of pages11
JournalFuture Cardiology
Volume4
Issue number1
DOIs
StatePublished - Jan 1 2008
Externally publishedYes

Fingerprint

Ubiquitin-Protein Ligases
Appetite
Proteasome Endopeptidase Complex
Heart Diseases
Ubiquitin
Cardiomegaly
Cardiomyopathies
Quality Control
Proteolysis
Myocardial Ischemia
Animal Models
Therapeutics
Proteins

Keywords

  • Atrogin-1
  • Bortezomib
  • Cardiac
  • CHIP
  • Hypertrophy
  • Ischemia
  • MDM2
  • MuRF1
  • Reperfusion
  • Velcade™

ASJC Scopus subject areas

  • Molecular Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Appetite for destruction : E3 ubiquitin-ligase protection in cardiac disease. / Willis, Monte; Schisler, Jonathan C.; Patterson, Cam.

In: Future Cardiology, Vol. 4, No. 1, 01.01.2008, p. 65-75.

Research output: Contribution to journalReview article

Willis, Monte ; Schisler, Jonathan C. ; Patterson, Cam. / Appetite for destruction : E3 ubiquitin-ligase protection in cardiac disease. In: Future Cardiology. 2008 ; Vol. 4, No. 1. pp. 65-75.
@article{f04b3b7fe58941d2ab7c3ffc95030e04,
title = "Appetite for destruction: E3 ubiquitin-ligase protection in cardiac disease",
abstract = "Over the course of 3 billion heartbeats in an average human lifetime, the heart must maintain constant protein quality control, including the coordinated and regulated degradation of proteins via the ubiquitin-proteasome system (UPS). Recent data highlight the specificity by which the UPS functions in the context of cardiac hypertrophy, ischemic heart disease and cardiomyopathies. Although curbing the appetite of the proteasome through the use of inhibitors in animal models of cardiac disease has proven effective experimentally recent studies report proteasome inhibition as being cardiotoxic in some patients. Therefore, focusing on specific regulatory components of the proteasome, such as members of the E3 ubiquitin-ligase family of proteins, may hold promise for targeted therapeutics of cardiac disease. This review focuses on the UPS, its specific role in cardiac disease and opportunities for novel therapies.",
keywords = "Atrogin-1, Bortezomib, Cardiac, CHIP, Hypertrophy, Ischemia, MDM2, MuRF1, Reperfusion, Velcade™",
author = "Monte Willis and Schisler, {Jonathan C.} and Cam Patterson",
year = "2008",
month = "1",
day = "1",
doi = "10.2217/14796678.4.1.65",
language = "English (US)",
volume = "4",
pages = "65--75",
journal = "Future Cardiology",
issn = "1479-6678",
publisher = "Future Medicine Ltd.",
number = "1",

}

TY - JOUR

T1 - Appetite for destruction

T2 - E3 ubiquitin-ligase protection in cardiac disease

AU - Willis, Monte

AU - Schisler, Jonathan C.

AU - Patterson, Cam

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Over the course of 3 billion heartbeats in an average human lifetime, the heart must maintain constant protein quality control, including the coordinated and regulated degradation of proteins via the ubiquitin-proteasome system (UPS). Recent data highlight the specificity by which the UPS functions in the context of cardiac hypertrophy, ischemic heart disease and cardiomyopathies. Although curbing the appetite of the proteasome through the use of inhibitors in animal models of cardiac disease has proven effective experimentally recent studies report proteasome inhibition as being cardiotoxic in some patients. Therefore, focusing on specific regulatory components of the proteasome, such as members of the E3 ubiquitin-ligase family of proteins, may hold promise for targeted therapeutics of cardiac disease. This review focuses on the UPS, its specific role in cardiac disease and opportunities for novel therapies.

AB - Over the course of 3 billion heartbeats in an average human lifetime, the heart must maintain constant protein quality control, including the coordinated and regulated degradation of proteins via the ubiquitin-proteasome system (UPS). Recent data highlight the specificity by which the UPS functions in the context of cardiac hypertrophy, ischemic heart disease and cardiomyopathies. Although curbing the appetite of the proteasome through the use of inhibitors in animal models of cardiac disease has proven effective experimentally recent studies report proteasome inhibition as being cardiotoxic in some patients. Therefore, focusing on specific regulatory components of the proteasome, such as members of the E3 ubiquitin-ligase family of proteins, may hold promise for targeted therapeutics of cardiac disease. This review focuses on the UPS, its specific role in cardiac disease and opportunities for novel therapies.

KW - Atrogin-1

KW - Bortezomib

KW - Cardiac

KW - CHIP

KW - Hypertrophy

KW - Ischemia

KW - MDM2

KW - MuRF1

KW - Reperfusion

KW - Velcade™

UR - http://www.scopus.com/inward/record.url?scp=38049174964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049174964&partnerID=8YFLogxK

U2 - 10.2217/14796678.4.1.65

DO - 10.2217/14796678.4.1.65

M3 - Review article

C2 - 19543439

AN - SCOPUS:38049174964

VL - 4

SP - 65

EP - 75

JO - Future Cardiology

JF - Future Cardiology

SN - 1479-6678

IS - 1

ER -